Open access · CC-BY
via OpenAlex
Telomere Shortening in Three Diabetes Mellitus Types in a Mexican Sample
Pavel Cuevas Diaz, Humberto Nicolini, Germán Alberto Nolasco-Rosales, Isela Esther Juárez‐Rojop, Carlos Alfonso Tovilla‐Zárate, Ester Rodríguez Sánchez, Alma Delia Genis Mendoza
Biomedicines · 2023 · ▲ 12 citations
Abstract
This study aimed to explore the role of telomere(definition) length in three different diabetes types: latent autoimmune diabetes of adulthood (LADA), latent autoimmune diabetes in the young (LADY), and type 2 diabetes mellitus (T2DM). A total of 115 patients were included, 72 (62.61%) had LADA, 30 (26.09%) had T2DM, and 13 (11.30%) had LADY. Telomere length was measured using real-time Polymerase Chain Reaction. For statistical analysis, we used the ANOVA test, X2 test, and the Mann–Whitney U test. Patients with T2DM had higher BMI compared to LADA and LADY groups, with a BMI average of 31.32 kg/m2 (p = 0.0235). While the LADA group had more patients with comorbidities, there was not a statistically significant difference (p = 0.3164, p = 0.3315, p = 0.3742 for each of the previously mentioned conditions). There was a difference between those patients with T2DM who took metformin plus any other oral antidiabetic agent and those who took metformin plus insulin, the ones who had longer telomeres. LADA patients had shorter telomeres compared to T2DM patients but not LADY patients. Furthermore, T2DM may have longer telomeres thanks to the protective effects of both metformin and insulin, despite the higher BMI in this group.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/biomedicines11030730
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Diaz, P.C., Nicolini, H., Nolasco-Rosales, G.A., Juárez‐Rojop, I.E., Tovilla‐Zárate, C.A., Sánchez, E.R., & Mendoza, A.D.G. (2023). Telomere Shortening in Three Diabetes Mellitus Types in a Mexican Sample. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines11030730
Vancouver
Diaz PC, Nicolini H, Nolasco-Rosales GA, Juárez‐Rojop IE, Tovilla‐Zárate CA, Sánchez ER, et al. Telomere Shortening in Three Diabetes Mellitus Types in a Mexican Sample. Biomedicines. 2023. doi:10.3390/biomedicines11030730.
BibTeX
@article{pavel2023Telome,
title = {Telomere Shortening in Three Diabetes Mellitus Types in a Mexican Sample},
author = {Pavel Cuevas Diaz and Humberto Nicolini and Germán Alberto Nolasco-Rosales and Isela Esther Juárez‐Rojop and Carlos Alfonso Tovilla‐Zárate and Ester Rodríguez Sánchez and Alma Delia Genis Mendoza},
journal = {Biomedicines},
year = {2023},
doi = {10.3390/biomedicines11030730},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Gerontology 2020
Citation only
The Association between Antidiabetic Agents and Leukocyte Telomere Length in the Novel Classification of Type 2 Diabetes Mellitus
The Journal of Clinical Endocrinology & Metabolism 2014
Citation only
β-Cell Telomere Attrition in Diabetes: Inverse Correlation Between HbA1c and Telomere Length
PLoS ONE 2020
Open access · CC-BY
From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis
Aging 2019
Preprint · CC-BY
Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes
European Heart Journal 2024
Citation only
Association of telomeres length with cardiovascular risk factors and arterial stiffness
Chronic Diseases and Translational Medicine 2021
Open access · CC-BY